| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/03/2000 | CA2302832A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/02/2000 | EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| 02/02/2000 | EP0975758A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/02/2000 | EP0975743A1 Inhibitors for urokinase receptor |
| 02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/02/2000 | EP0975659A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975631A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands |
| 02/02/2000 | EP0975623A2 Indazole amide compounds as serotoninergic agents |
| 02/02/2000 | EP0975617A1 Inhibitors of cholesterol esterase |
| 02/02/2000 | EP0975602A1 Imidazole and imidazoline derivatives and uses thereof |
| 02/02/2000 | EP0975598A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide |
| 02/02/2000 | EP0975573A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 02/02/2000 | EP0975347A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/02/2000 | EP0975346A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 02/02/2000 | EP0975340A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | EP0751783B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic use of aminoacetylmercapto derivatives |
| 02/02/2000 | EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/02/2000 | EP0706532B1 Peptides having endothelin antagonictic activity,their preparation and pharmaceutical compositions |
| 02/02/2000 | EP0592557B1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 02/02/2000 | CN1243510A Tricyclicbenzo [3] isoindole and benzo (h) isoquinoline |
| 02/02/2000 | CN1243000A Oral liquor for tonifying brain and reducing blood fat and its production method |
| 02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 02/01/2000 | US6020510 Cytoprotective compounds |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
| 02/01/2000 | US6020362 Glycoprotein IIB IIIA antagonists |
| 02/01/2000 | US6020350 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020348 Endothelin receptor antagonists |
| 02/01/2000 | US6020345 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 02/01/2000 | US6020336 Indole and indazole compounds |
| 02/01/2000 | US6020330 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | CA2144947C Serotonin receptor agents |
| 02/01/2000 | CA2109575C Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000004027A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | WO2000004018A1 Ergoline amine derivatives with blood pressure lowering effect |
| 01/27/2000 | WO2000004015A1 1-4-dihydropyridines with benzodioxo carbonyl group as calcium blockers |
| 01/27/2000 | WO2000004012A1 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 01/27/2000 | WO2000004011A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000003997A1 Thiobenzimidazole derivatives |
| 01/27/2000 | WO2000003996A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | WO2000003994A2 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | WO2000003987A1 1,4-dihydropyridines as calcium blockers |
| 01/27/2000 | WO2000003981A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | WO2000003978A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
| 01/27/2000 | WO2000003712A1 1-4-dihydropyridines with pyridinyl group as calcium blockers |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO2000003691A1 Systems and methods for local delivery of an agent |
| 01/27/2000 | WO2000003677A2 Use of bisphosphonates in the treatment of vascular restenosis |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999058527A3 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 01/27/2000 | WO1999056734A3 Transdermal therapeutic system for the administration of candesartan |
| 01/27/2000 | DE19833119A1 Storage-stable injectable solution of vasodilator and beta blocker Carvedilol contains buffer, organic solvent, antioxidant and complexing agent |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | DE19832191A1 New N-acylated ergoline amine derivatives, are alpha-1 adrenoreceptor blockers useful as potent, well tolerated antihypertensive agents |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2338059A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2338039A1 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 01/27/2000 | CA2338037A1 Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof |
| 01/27/2000 | CA2337881A1 Novel ergoline amine derivatives and their use |
| 01/27/2000 | CA2337481A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
| 01/27/2000 | CA2337194A1 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | CA2336950A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973793A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973774A1 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinone derivatives |
| 01/26/2000 | EP0973769A1 Process for preparing eprosartan |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973744A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/26/2000 | EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |